Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis.

JCO oncology practice - 1 May 2021

Costa Philippos A, Saul Eduardo E, Paul Yonette, Iyer Sunil, da Silva Laercio Lopes, Tamariz Leonardo, Lopes Gilberto

Abstract excerpt

PURPOSE: Inferior outcomes of Black patients with lung cancer compared with other racial groups are often linked to socioeconomic factors. It is crucial to determine whether a varying prevalence of targetable mutations limits treatments and contributes to disparities. MATERIALS AND METHODS: We conducted a meta-analysis on the prevalence of lung cancer EGFR, ALK, ROS-1, and BRAF mutations in Black patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prevalence

Share to Turkey

Source

Identifiers

PMID: 33974815
DOI: 10.1200/OP.20.00961

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of Targetable Mutations in Black Patients With Lung Cancer: A Systematic Review and Meta-Analysis.PMID 33974815Read ↗

Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical centerSemantic proximity Read ↗

Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.Semantic proximity Read ↗

Race-Associated EGFR and KRAS Mutation Profiles in Lung Adenocarcinoma.Semantic proximity Read ↗

Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumSemantic proximity Read ↗

Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?Semantic proximity Read ↗

Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis.Semantic proximity Read ↗

Genomic landscape of lung adenocarcinomas in different racesSemantic proximity Read ↗

Racial diversity of actionable mutations in non-small cell lung cancer.Semantic proximity Read ↗

Lung cancer mutations and use of targeted agents in Hispanics.Semantic proximity Read ↗

Real World Outcomes for the Efficacy and Safety of Osimertinib in Black Patients With Nonsmall Cell Lung Cancer.Semantic proximity Read ↗

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.Semantic proximity Read ↗

Lung carcinoma in African Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.